More tools:Markets·Screener·Research·Chat

NovaBridge Biosciences American Depositary Shares (NBP) Financial Statements

NovaBridge Biosciences American Depositary Shares
SIC 4922 · NATURAL GAS TRANSMISSION
FIGI BBG00QQ8DG97
XNAS · usd
1.70▼ 0.08 (-4.49%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close1.78
Day's Range1.68 – 1.80
52-Week Range1.46 – 5.19
Volume306.6K
Avg Volume251.7K
Share Statistics
Shares Outstanding
Employees30
ExchangeXNAS
Listed2020-01-17
Share count as of June 30, 2026
Loading Income Statement…
Key questions about NovaBridge Biosciences American Depositary Shares (NBP)
What is NovaBridge Biosciences American Depositary Shares's Market Cap?
NovaBridge Biosciences American Depositary Shares's Market Cap is $453.6M, based on as-reported figures from SEC (XBRL) filings.
What is NovaBridge Biosciences American Depositary Shares's Enterprise Value?
NovaBridge Biosciences American Depositary Shares's Enterprise Value is $262.7M, based on as-reported figures from SEC (XBRL) filings.
What is NovaBridge Biosciences American Depositary Shares's EV / EBITDA?
NovaBridge Biosciences American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is NovaBridge Biosciences American Depositary Shares's Net Income (TTM)?
NovaBridge Biosciences American Depositary Shares's Net Income (TTM) is -$75.5M, based on as-reported figures from SEC (XBRL) filings.
What is NovaBridge Biosciences American Depositary Shares's EBITDA?
NovaBridge Biosciences American Depositary Shares's EBITDA is -$122.5M, based on as-reported figures from SEC (XBRL) filings.
What is NovaBridge Biosciences American Depositary Shares's Diluted EPS (TTM)?
NovaBridge Biosciences American Depositary Shares's Diluted EPS (TTM) is -0.28, based on as-reported figures from SEC (XBRL) filings.
What is NovaBridge Biosciences American Depositary Shares's Net Debt?
NovaBridge Biosciences American Depositary Shares's Net Debt is -$190.8M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Expenses
Research and development expenses
Administrative expenses
Total Expenses
Loss from operations
Interest income, net
Other income, net
Loss before income tax expense
Income tax expense—
Net loss
Net loss attributable to noncontrolling interests
Net loss attributable to shareholders of NovaBridge
Comprehensive loss attributable to redeemable noncontrolling interests
Comprehensive loss attributable to shareholders of NovaBridge
Net loss per share - basic
Net Ioss per share - diluted